Table 2. Profiles of Patients with ATF4-Positive or ATF4-Negative ESCCs.
Clinicopathological Features | Tumor ATF4 Expression | P Value | |
Negative(n = 51) | Positive(n = 117) | ||
Age | 64.3(9.8) | 63.9(9.7) | 0.828 |
Sex | |||
Male | 35 | 82 | 0.850 |
Female | 16 | 35 | |
Drinking | |||
Yes | 26 | 63 | 0.732 |
No | 25 | 54 | |
Tumor site | |||
Upper | 11 | 29 | 0.707 |
Middle | 24 | 47 | |
Lower | 16 | 41 | |
Tumor differentiation | |||
Well | 26 | 53 | 0.549 |
Moderate | 16 | 47 | |
Poor | 9 | 17 | |
TNM stage | |||
I | 21 | 17 | 0.001 |
II | 19 | 56 | |
III | 11 | 44 | |
Lymph node metastasis | |||
Absent | 43 | 52 | 0.000 |
Present | 8 | 65 |